News 5 Cleveland: Cleveland Heights settles lawsuit with DNA exoneree for $4 million
Ohio Innocence Project assisted wrongfully convicted man who spent 17 years behind bars
Christopher Miller may finally get the justice he deserves.
Miller, 46, served nearly 17 years behind bars after being wrongfully convicted of a crime he did not commit. With the help of the Ohio Innocence Project at UC Law, Miller was exonerated by DNA in 2018.
And now the city of Cleveland Heights will pay $4 million to settle a federal civil rights lawsuit by Miller.
News 5 Cleveland reported the story in a recent broadcast.
Miller was wrongfully convicted of the 2001 sexual assault and robbery of a Cleveland Heights woman. He always maintained his innocence and offered an alibi — Miller was asleep with his girlfriend miles away when the assault occurred. But police investigating the assault tracked the victim’s cell phone to Miller, who said he bought it from a local drug dealer.
A second suspect, Richard Stadmire, also was arrested and convicted. A third suspect in the case, Charles Boyd, testified that Miller was an accomplice in the crime. Miller maintained that Boyd was lying and that they had never met. Boyd later recanted his testimony.
OIP lawyer Brian Howe filed a motion in 2017 to retest DNA evidence in the case and the new test exonerated Miller.
"The DNA testing results showed definitely not only that Mr. Miller was excluded from the sexual assault kit, but DNA testing was able to identify both actual perpetrators in this case," Howe told News 5 Cleveland.
The DNA profiles matched Stadmire and Boyd.
"At some point, police decided that Mr. Miller was responsible for this crime," Howe told News 5 Cleveland. "At that point, the evidence was marshaled to support that conclusion."
Listen to the News 5 Cleveland report.
Learn more about Christopher Miller’s journey.
Featured top image: Christopher Miller hugs his daughters De'Nazha, left, and Chareale in 2018 after his release outside the Cuyahoga County Justice Center. Photo/provided.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.